Home Tools
Log in
Cart

Search Result

Search Results for " ppi "

20

Compounds

Cat No. Product Name Synonyms Targets
T28441 PPI-1019 PPI1019,Apan Beta Amyloid
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).
T10217L Abarelix R3827,PPI 149 GNRH Receptor
Abarelix (PPI 149) is a potent gonadotrophin-releasing hormone (GnRH) antagonist, which is used for prostate cancer treatment.
T69258 PPI-2458
PPI-2458 is a synthetic derivative of fumagillin with antineoplastic and cytotoxic properties. PPI-2458 irreversibly inhibits the enzyme methionine aminopeptidase type 2 (MetAP2), thereby preventing abnormal cell growth ...
T72785 PRMT5:MEP50 PPI
PRMT5:MEP50 PPI, a pioneering inhibitor of the PRMT5:MEP50 protein-protein interaction (PRMT5:MEP50 PPI), demonstrates anti-tumor and anti-proliferative effects in lung and prostate cancer cells.
T62447 Paltimatrectinib PBI-200,PPI-5278 Trk receptor , Tyrosine Kinases
Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA).Paltimatrectinib is used in the study of bladder, breast and colorectal cancers.
T7387 Ceftaroline fosamil TAK-599,PPI0903 Antibacterial , Antibiotic
Ceftaroline fosamil (TAK-599) is a cephalosporin, with activity against Gram-positive pathogens.
T79457 PEX5-PEX14 PPI-IN-1
PEX5-PEX14 PPI-IN-1 (Compound 8) is a PEX14-PEX5 protein-protein interaction (PPI) inhibitor that disrupts the interaction between PEX5 and TbPEX14 with an inhibitory constant (Ki) of 53 μM. It effectively inhibits the b...
T10217 Abarelix Acetate (183552-38-7 free base) PPI 149 Acetate,Abarelix Acetate Others
Abarelix (PPI 149; R 3827) Acetate is a potent gonadotrophin-releasing hormone (GnRH) antagonist, used for prostate cancer research.
T81503 PEX5-PEX14 PPI-IN-2
Compound 12, also known as PEX5-PEX14 PPI-IN-2, is a PEX14-PEX5 protein-protein interaction (PPI) inhibitor with half-maximal effective concentration (EC50) values of 5 µM in T. b. brucei and 17 µM in HepG2 cells. It is ...
T82758 CDK9-Cyclin T1 PPI-IN-1 CDK
CDK9-Cyclin T1 PPI-IN-1 (Compound B19) is a selective inhibitor of the CDK9-Cyclin T1 protein-protein interaction (PPI), suppressing cell proliferation in TNBC MDA-MB-231 cells with an IC50 of 0.044 μM and inducing apopt...
T8784 IGS-1.76 Others
IGS-1.76 exhibits pronounced affinity towards hNCS-1 and effectively modulates the interaction between hNCS-1 and Ric8a. Moreover, IGS-1.76 proficiently inhibits the complex formed by human NCS-1 and Ric8a.
T26859 BMS-8 PD-1/PD-L1
BMS-8 is a novel inhibitor of the PD-1/PD-L1 interaction (IC50: 7.2 μM) by binding directly to PD-L1 and inducing the formation of PD-L1 homodimers.
T4647 M2I-1 M2I 1 Others
M2I-1 a small Mad2 inhibitor-1. the first small molecule inhibitor targeting the binding of Mad2 to Cdc20, an essential proteinprotein interaction (PPI) within the SAC. It can disturbs conformational dynamics of Mad2 cri...
T6889 MI-136 Apoptosis , Epigenetic Reader Domain , Androgen Receptor
MI-136 inhibits expression of androgen receptor (AR) target genes that DHT induced.
T9039 HIV-1 Nef-IN-1 HIV Protease
HIV-1 Nef-IN-1 is an inhibitor of HIV-1 Nef protein. It efficiently competes for Nef-SH3Hck interactions(Kd : 6.7 μM).
T9044 SORT-PGRN interaction inhibitor 1 Neurotensin Receptor
SORT-PGRN interaction inhibitor 1 is a potent sortilin-progranulin interaction inhibitor(IC50 of 2 μM).
T13018 SU3327 halicin JNK
SU3327 (halicin) is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
T8421 TED-347 YAP
TED-347 is an irreversible and covalent inhibitor of TEAD4-Yap1 protein-protein interaction(EC50 of 5.9 μM), and inhibits glioblastoma cell viability.
T8216 T-1101 tosylate TAI-95 tosylate Apoptosis , Microtubule Associated
T-1101 tosylate (TAI-95 tosylate) is an inhibitor of Hec1/Nek2, with antitumor activity.
T6928 Pantoprazole SKF96022,BY1023 Apoptosis , Proton pump , Autophagy
Pantoprazole (BY1023) is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.
1 2 3 4 5
TargetMol